✦ LIBER ✦

The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy – a retrospective audit

✍ Scribed by W.L. NG; S.A. DELLA-FIORENTINA

Book ID: 108710754
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 101 KB
Volume: 19
Category: Article
ISSN: 0961-5423
DOI: 10.1111/j.1365-2354.2009.01068.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized study of aprepitant, ondans

A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy

✍ Winnie Yeo; F. K. F. Mo; J. J. S. Suen; W. M. Ho; S. L. Chan; W. Lau; J. Koh; W. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 184 KB

Cost-Effectiveness of Aprepitant for the

Cost-Effectiveness of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy

✍ Susan Moore; John Tumeh; Steven Wojtanowski; Christopher Flowers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 743 KB

Efficacy and tolerability of aprepitant

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy

✍ Jørn Herrstedt; Hyman B. Muss; David G. Warr; Paul J. Hesketh; Peter D. Eisenber 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Aprepitant for the prevention of chemoth

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study

✍ Bernardo L. Rapoport; Karin Jordan; Judith A. Boice; Arlene Taylor; Carole Brown 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 174 KB

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Effectiveness of a single-day three-drug

Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy

✍ Steven M. Grunberg; Matthew Dugan; Hyman Muss; Marie Wood; Susan Burdette-Radoux 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 148 KB